In recent years, pesticides have captured the attention of both policy-makers and the general public. A particular focus has been the transparency of the EU-level procedure for approving active substances, spurred by controversies surrounding the active substance glyphosate. Active substances are the ingredient in pesticides with the pesticidal effect. Once an active substance is approved at EU level, the pesticide containing that active substance must be authorised by each Member State. For this purpose, the EU's 2009 Plant Protection Product Regulation divides Member States into three zones -Northern, Central and Southern -within which, zonal rapporteur Member States evaluate applications for authorisation. National authorisation decisions are based on these zonal evaluations. This novel system governing pesticides is under-researched. Furthermore, unlike active substance approval, the transparency of pesticide authorisation escapes public and policy scrutiny. Drawing on empirical research conducted for the European Parliament, this article evaluates the transparency of the zonal pesticide authorisation procedure. It thus contributes to the literature on transparency a detailed exploration of transparency in a highly complex, decentred and polycentric risk regulation regime. While it finds that the zonal pesticide authorisation procedure, generally speaking, does not operate transparently, it argues further that levels of transparency within the regime as a whole may vary significantly depending on multiple different factors. It introduces the concept of 'chiaroscuro regulation' to characterise and understand these varying levels of transparency across different elements of the regime and considers some of its implications.
I. INTRODUCTION
Pesticides frequently hit headlines. Controversies over the safety of glyphosate and neonicotinoids represent the two highest-profile examples. 1 While these controversies shine valuable light on certain elements of EU pesticides regulation, other elements operate largely in darkness, escaping the glare of public, and academic, scrutiny. My aim here is to chase some of the shadows from these elements. The article originates in research conducted for a European Implementation Assessment * I am grateful to Dr Steven Vaughan and Prof Cosmo Graham for their comments on earlier drafts of this article. I presented parts of this research at the 2018 LSA annual meeting in Toronto and the 2018 SLS annual conference in London. My thanks to the participants for their thoughts. I am also grateful to the editors and anonymous reviewer for their helpful comments. Any mistakes are my own. 1 See, for example, Claire Stam, 'Glyphosate has adverse health effects from doses considered safe, study shows' (17 May 2018) https://www.euractiv.com/section/agriculture-food/news/glyphosate-has-adversehealth-effects-from-doses-considered-safe-study-shows/; Sarantis Michalopoulos, 'Environmentalists clash with EFSA over neonicotinoids ban 'exceptions'' (9 August 2018) https://www.euractiv.com/section/agriculture-food/news/environmentalists-clash-with-efsa-overneonicotinoids-ban-exceptions/. pesticide authorisation procedure specifically, offer fertile ground for research, not only within the environmental law specialism but also with respect to EU regulation and governance generally. The regime established by the Regulation is characterised by the inter-play of different actors at different levels of governance -EU, national, as well as 'zonal' -and requires Member State competent authorities (CAs) to work together on the highly technical (in both scientific and legal terms) matters of evaluating and regulating the risks posed by pesticides and their ingredients. Furthermore, tensions between, for example, the public interest in safety and transparency and commercial/industrial interests in confidentiality and ensuring the availability of pesticides can result in these matters of evaluation and regulation becoming highly politicised. For these (and other) reasons, EU pesticides regulation presents openings to explore and further develop theory regarding, for example, risk regulation, decentred/polycentric regulation and the operation of regulatory agencies or networked, collaborative or multi-level governance. For now, the article seeks firstly, to understand and evaluate the level(s) of transparency achieved by the Regulation. Secondly, it uses this analysis to offer a more general observation about transparency in a highly complex, polycentric risk regulation regime.
The article is structured as follows. Part II discusses transparency as a principle of governance. First, it contextualises transparency in the regulatory reforms sweeping Europe since the mid-1970s. Secondly, it presents a normative understanding of transparency in the context of a highly technical and complex, risk-based regulatory regime. Implementing transparency may depend on myriad requirements. The analysis in this article takes it as consisting of clarity with regard to the rules of the game, access to information and wider stakeholder and public participation in decisionmaking. Part III first discusses the policy behind the Regulation and secondly, explores briefly the active substance approval procedure and recent transparency-related policy and legislative developments relating to that procedure. Part IV is the core of the article. Part IV A presents a description of the pesticide authorisation procedure and evaluates the transparency of this procedure against the three requirements defined in Part II. Part IV B highlights the importance of transparency in pesticide authorisation as well as active substance approval.
Part V advances two arguments. Working from the analysis in Part IV, I argue that the zonal pesticide authorisation procedure, generally speaking, does not operate transparently. However, the transparency-focused analysis of the Regulation provides the basis for a second, more nuanced argument. I argue that levels of transparency within the regime established by the Regulation as a whole may vary significantly depending on multiple different factors. These factors include national regulator practice, actor, level of decision-making procedure (EU, zonal, national) and regulatory object. It is, as a consequence, impossible to draw universal and fixed conclusions about the transparency of regulatory actors and procedures in the context of such a complex, polycentric and continuously evolving regulatory regime. The result is a regime typified by varying shades of illumination and inumbration across its different elements, all with the potential to fluctuate; a phenomenon I define as 'chiaroscuro regulation'. 10 I use this concept to describe and encapsulate characteristics of this regime and its levels of transparency, as revealed by the analysis in this Part. These characteristics include the sharp contrasts in transparency within the regime, the relevance of the audience when discussing transparency and the significance of the gradual nature of developments in transparency. As a descriptive concept, it aims to epitomise and thereby aid understanding of the nature of transparency in complex regimes. Part V closes with consideration of some of the consequences of chiaroscuro regulation. Part VI concludes by highlighting the contingency of transparency, in practice, on those factors identified and the potential implications for democratic accountability and the quality of decisions.
II. TRANSPARENCY IN CONTEXT
Transparency is complex and, unlike pesticides regulation, increasingly elucidated by a rich and growing literature. 11 Much of this literature is theoretical. It concerns reasons for and against transparency and measures for achieving transparency, 12 often situated in the broader context of regulatory reform across Europe since the mid-1970s. Briefly, this reform was characterised by, inter alia, increasing delegation of regulatory powers to independent regulatory authorities at national and supranational levels. 13 This 'agencification', while affecting mainly economic regulation, also touched social regulation, which encompasses the fields of, inter alia, pharmaceuticals, food safety and environmental regulation, 14 and therefore pesticides regulation. Independence from elected officials, and therefore traditional methods of accountability, prompted concerns. 15 The public cannot hold an authority to account unless its activities are first made visible. 16 Thus transparency, being associated with making the exercise of power accessible or visible, 17 became a crucial tool for ensuring accountability. Increased transparency has also been a response to the secrecy and opacity associated with previous regulatory styles and scandals. 18 For example, transparency was central to post-BSE food safety regulation reform, 19 and the constitution of both the European Food Safety Authority (EFSA) and the UK's Food Standards Agency. 20 Improving the transparency of regulatory science was at the heart of EU reforms aimed at raising public confidence its law and policy on food safety at the turn of the century. 21 These developments in regulation have coincided with a diversification of regulatory arenas, leading to the decentring and polycentricity of regulatory authority, increasingly scattered across multiple interdependent or networked, state and non-state actors in multiple sub-national, national 11 A good starting point is C Hood and D Heald (eds), Transparency: The Key to Better Governance? (Oxford University Press, 2006) . 12 See contributions to Hood and Heald, note 11 above. 13 and transnational locations. 22 Challenges include identifying the responsible institution in a progressively complex institutional landscape. With respect to independent regulators, a separate, independent identity has been argued to enhance transparency and openness, 23 promoting visibility and control and accountability to dense networks of actors extending beyond the state. 24 Other challenges include the blurring of the boundaries between expert advice and policy, 25 and between public and private. 26 Dispersal of regulatory responsibility or the pooling of information on risks from different sources may be exploited to institutionalise ambiguity and thereby avoid allocation of blame or liability simultaneously impeding the ability of citizens to understand the regime, 27 although ambiguity around authority can also have positive or productive consequences. 28 One important hallmark of decentred regulation, for this article, is the fragmentation of knowledge. Beyond the familiar potential for information asymmetry between regulator and regulatee, within this 'regulatory space', resources, including regulatory authority, 'information, wealth and organisational capacities' and the knowledge and oversight necessary for problem-solving and effective regulation are dispersed across different state and non-state organisations, rather than monopolised by a hierarchical state. 29 These combined developments intensify problems of accountability. 30 They have also prompted calls for greater transparency. 31 Transparency is not a transcendent principle; its meaning and purpose vary depending on context. 32 However, scholarship reveals certain norms which transparency may often encompass. It is possible therefore, drawing on literature on transparency, relevant EU law and policy and by reference to the specific characteristics of pesticides regulatory regime, to identify requirements for transparency in the context of this, and perhaps other, complex, transnational risk regulation regimes. This article takes transparency as consisting of three requirements. It is against these requirements that I evaluate the transparency of the Regulation in Part IV A. Firstly, clarity with regard to the rules of the game. Extending transparency to the 'rules, data and informational requirements … used to make decisions' is argued to build confidence in the regulator amongst publics and the regulated industry. 33 The Regulation establishes complex procedures which operate differently across Member States. 34 Clear descriptions of these procedures and how they operate in the national context would facilitate understanding as well as the involvement of stakeholders and civil society, the third requirement, discussed below.
Secondly, access to information. Narrow definitions of transparency would refer to 'minimal openness of process, access to documents and, publication of official measures'. 35 A requirement, for example, that public authorities give reasons for their decisions activates accountability mechanisms, including judicial review, allowing citizens to defend their rights and the courts to exercise their supervisory functions as well as supporting public participation. 36 It may also encourage decision-makers to balance the pros and cons of a decision more than those whose reasoning remains unlit, thereby helping to control discretion. 37 Some argue that openness, transparency and honesty, generally, increase trust or confidence in organisations, while secrecy destroys it. 38 Such trust may, furthermore, support a regulator's legitimacy. 39 The EU endorses many of the claims made of transparency. For example, the Court of Justice of the EU (CJEU) and EU legislation have supported public access to information for, inter alia, its contribution to transparency and democratic accountability. 40 In addition, Directive (EC) 2003/4 recognises the contribution increased public access to environmental information makes to 'a greater awareness of environmental matters, a free exchange of views, more effective participation by the public in environmental decision-making and, eventually, to a better environment'. 41 Despite these benefits, there are potential drawbacks to enhancing transparency, suggesting the need for care in promoting access to information. Transparency may in fact decrease trust and cause harm. 42 For example, it could encourage members of the public to make their own decisions about risks, instead of relying on expert regulators. 43 Publishing unfiltered scientific findings could cause public alarm with drastic public health consequences. 44 Furthermore, transparency may precipitate disagreement disruptive of the bases and procedures of decision-making. 45 This may be true especially where, as with pesticides, assessments of risk are already contested. 46 As discussed in Parts III B and IV A, pesticides regulation is information-heavy. Applicants generate and submit large amounts of information as part of their applications for approval or authorisation and decision-makers rely on this information to make decisions. More specifically, 34 45 Fisher, note 17 above, p 305. 46 Bozzini, note 8 above, ch 4. under the Regulation, authorisation decisions are based almost exclusively on scientific evidence, in the form of a risk assessment. 47 Where scientific knowledge forms the basis of public decisions with significant implications for human health and the environment, as with pesticides, democratic control 'demands some ability on the part of a polity to evaluate the knowledge claims that justify actions taken on its behalf'. 48 Public reporting, and therefore the possibility of public scrutiny, of the relevant information may prevent regulators adjusting evidence to suit a policy position. 49 Finally, improved public understanding of the bases for decisions enabled by transparency, particularly access to information, may ensure more effective participation, the third requirement. 50 Thirdly, wider stakeholder and public participation in decision-making. Beyond access to information, consultation is central to transparency. 51 It has been argued that full transparency is only achieved through knowledge of decision-making acquired by direct participation. 52 That said, full transparency through participation may not maintain or enhance trust in a regulator unless the public's impression of the reliability of its internal operations actually improves as a result. 53 Within the EU, the Commission has emphasised 'effective and transparent consultation' and a 'reinforced culture of consultation and dialogue', recognising the importance of public participation for good governance generally (albeit, there, in the context of policy formation rather than regulatory decision-making). 54 Recital 3, Directive (EC) 2003/35 providing for public participation in respect of the drawing up of certain plans and programmes relating to the environment states that '[e]ffective public participation in the taking of decisions enables the public to express, and the decision-maker to take account of, opinions and concerns which may be relevant to those decisions, thereby increasing the accountability and transparency of the decision-making process and contributing to public awareness of environmental issues and support for the decisions taken'. 55 The Lisbon Treaty acknowledges the link between openness, transparency and participation. 56 Likewise, the General Food Law conceives transparency as entailing openness and public consultation. 57 Furthermore, social and ecological uncertainty characterise the contexts of pesticide use. 58 Assessment of the risks pesticides pose is a highly complex task, presenting challenges for risk assessors and regulators. 59 For example, the behaviour of farm workers applying pesticides in the field is unpredictable. 60 So too, are the indirect and cumulative effects of pesticides on whole ecosystems. 61 The reporting of expert deliberations, uncertainties, ambiguities and disagreements for example, may open up decision-making and enhance transparency. 62 Given the often controversial nature of risk-based decision-making and the need for, and inevitability of, assumptions and value judgments in the assessment and management of risk, 63 especially in situations of uncertainty, public involvement may benefit decision-making by incorporating citizens' values in the weighing of uncertain benefits against uncertain risks. 64 The availability of more information and perspectives through wider participation may generate better decisions, 65 for example where scrutiny enables the identification of errors or contributions aid problem-solving. 66 Even where improved decisions do not result, participation is regarded as having normative value. 67 Finally, and in more practical terms, decisions about pesticides affect numerous stakeholders and publics across the EU, who should therefore be granted a voice. Furthermore, recent campaigns demanding greater transparency demonstrate an appetite for increased citizen involvement in these decisions. 68 In addition to elaborating various requirements of transparency, much of the literature on transparency is punctuated with examples of more or less transparent laws, regulation or regulators and sometimes more extended analyses of the achievement of transparency by a particular legal instrument. 69 There is, however, less work which presents a sustained exploration of transparency in the context of a single complex, transnational regulatory regime or how transparently such a regime operates in practice. This article's contribution to the literature is such an exploration of transparency. 70 
III. EU PESTICIDES POLICY AND REGULATION: ACTIVE SUBSTANCE APPROVAL AND POLICY DEVELOPMENTS

A. Policy
Pesticides have long been contested. They are valued for their contribution to maintaining crop yields and the production of affordable fruit and vegetables, as well as bolstering the economy more generally. In 2014, for example, the EU market for pesticides was worth almost €10 billion. 71 They also, however, pose risks to human health and the environment and may themselves undermine crop protection through the elimination of natural predators and increasing pesticide resistance. 72 The turn of the century witnessed a radical change in EU pesticides policy. 73 This led to repeal of the Regulation's predecessor directive ('the Directive'). 74 Reviews of the Directive found its procedures for assessing active substances and pesticides to be inefficient, subject to delays and to encourage duplication of administrative work among Member States. 75 Bozzini highlights three particular problems with the Directive which hindered fulfilment of the EU's pesticide policy goals. Firstly, the challenges of establishing harmonised data requirements and approval criteria significantly delayed the assessment of active substances already on the market and the implementation, generally, of the Directive. Secondly, those delays perpetuated the existing market fragmentation, improving little on the pre-Directive situation in which common rules were absent. Finally, the delays in assessing active substances in use, alongside scarce and incomplete data, aggravated public health concerns. 76 Multiple motivations drove the reform, including reinforcing a high level of health and environmental protection, improved functioning of the EU internal market, harmonising availability of pesticides between farmers in different Member States and increasing transparency. 77 While the Regulation retained the dual assessment system established under the Directive, 78 it introduced a new zonal system for authorising pesticides, as mentioned in the Introduction and discussed in greater detail in Part IV A. Mutual recognition of pesticide authorisations within zones emerged as a means to achieve the aims of the reform and address the failures of mutual recognition under the Directive. 79 Overall, the zonal system and the compulsory mutual recognition within zones it would facilitate, sought administrative efficiency through simplifying the authorisation procedure, increasing work-sharing and co-ordination between Member States within zones to avoid unnecessary duplication of work and reduce administrative and financial burdens for industry and Member States, speeding up decision-making and increasing efficiency. 80 The Regulation's recitals also reflect these aims. 81 In terms of policy on transparency during the reform, efforts to improve transparency in pesticides regulation focused mainly on the procedure for approving active substances rather than pesticide authorisation, 82 a trend which continues today. 83 The transparency of the pesticide authorisation process under the Directive was identified as a problem worthy of attention. 84 The European Parliament considered 'the greatest possible transparency in licensing and use … to be essential'. 85 It also criticised the system under the Directive for its lack of public access to information. 86 It sought, therefore, to amend earlier drafts of the Regulation to ensure public access to information regarding applications for pesticide authorisations and to enhance the transparency of its procedures generally. 87 The zonal system was a compromise between a fully centralised decision-making approach (pesticide authorisation at EU level) and the decentralised system of national authorisations under the Directive. 88 Policy sheds little explicit light on how the system was conceived, its design or on any balancing of administrative efficiency against other values, such as transparency. Priorities are clear, however, in the iterations of the legislative text: the zonal system survived European Parliament objections that zones are arbitrary and conditions not comparable. 89 However, European Parliament amendments to enhance transparency survive in either a weakened form or not at all.
B. Active substance approval
Active substances are approved at EU level, with the involvement of EFSA and the Commission, aided by comitology. Manufacturers submit an application, consisting of a complete and summary dossier containing the necessary data requirements, 90 for approval to a specific 'rapporteur Member State'. 91 Summary dossiers are made available to the public, minus any information deemed confidential pursuant to Article 63. 92 The rapporteur Member State must conduct 'an independent, objective and transparent assessment in the light of current scientific and technical knowledge' of the information provided to determine 'whether the active substance can be expected to meet the approval criteria' in Article 4. 93 These criteria largely relate to the safety and efficacy of the active substance and are discussed further in Part IV B.
The rapporteur Member State produces a 'draft assessment report' which EFSA makes available to the public (minus confidential information), for a 60 day consultation period. 94 EFSA adopts a conclusion on whether the active substance can be expected to meet the Article 4 criteria and makes it available to the Commission, Member States and the public. 95 Taking into account the draft assessment report and EFSA's conclusion, the Commission produces a 'review report' and draft regulation, providing for approval, or not, of the active substance, which it submits to the Standing Committee on Plants, Animals, Food and Feed (comitology). 96 apply for authorisation to market the pesticide containing that approved active substance. 97 The Commission is required to maintain a publicly available list of approved active substances. 98 A recent study supporting the regulatory fitness (REFIT) evaluation of the Regulation examined the transparency of the active substance procedure. While it found that EFSA publishes a range of information, including summary dossiers, rapporteur draft assessment reports, reasoned opinions and conclusions on pesticides and member-lists and minutes of pesticides peer review expert meetings, the quality of this information has been criticised as being either too complex or too basic and uninformative. 99 With respect to public participation, although there is a 60 day consultation period, stakeholders faced challenges to contributing due to a lack of resources and the tight timeframes, NGOs regarded the opportunities for civil society involvement to be insufficient and over a third of stakeholders felt that their contributions were not valued. 100 Despite these criticisms, compared to pesticide authorisation (discussed below), this procedure is fairly transparent, in terms of public access to key documents and information and at least the existence of an opportunity for consultation. However, two recent events in particular led to proposals to change the EU level procedure: the 2017 European Citizens' Initiative (ECI) 'Stop Glyphosate', 101 and a REFIT evaluation of the General Food Law. 102 Their combined criticisms, foreshadowing the criticisms highlighted by the REFIT evaluation of the Regulation and largely supported by the European Parliament's ENVI Committee, 103 identified a lack of trust in EU regulatory decision-making stemming from the non-disclosure of data, the industry source of that data, reliance on unpublished studies and confidentiality requirements, in place to protect commercial interests. 104 The REFIT evaluation of the General Food Law found that civil society regarded many authorisation procedures in EU food legislation as lacking transparency and advised EFSA to 'adapt its way of working to the new expected levels of transparency' in order to protect its reputation. 105 The ECI demanded greater transparency specifically in the active substance approval procedure. 106 In response, the Commission committed to enhancing the transparency of the active substance approval procedure by adjusting the balance between disclosure of information and ensuring commercial confidentiality, where legitimate, through for example, increasing public access to studies contained in applications. 107 Its subsequent legislative proposal aims to enhance the transparency of EFSA's risk assessment procedures in the area of food law in order to increase its 97 PPPR, Art 29(1)(a), see Part IV A. 98 PPPR, Art 13(4). 99 legitimacy and public confidence in its work. 108 Proposed measures include making public scientific data and information contained in authorisation applications under EU food law as early as possible and providing for consultation of stakeholders to identify whether other relevant scientific data or studies are available, alongside stricter requirements with respect to the disclosure of information about EFSA's activities and a higher threshold for confidential treatment of information contained in applications. 109 Amendments proposed specifically to the Regulation ensure that the above proposed changes apply to active substance approval. Most notably, a new Article 10 requires EFSA to make public both dossiers submitted by applicants for approval, not just summary dossiers. 110 Little changes with respect to pesticide authorisation, although the higher threshold for confidential treatment appears to apply. 111 However, how some of the proposed provisions will interact with current provisions on confidentiality is unclear. 112 On the whole, provisions explicitly enhancing transparency remain confined to active substance approval.
IV. TRANSPARENCY AND PESTICIDES REGULATION
A. Pesticide evaluation and authorisation
As mentioned, the Regulation divides EU Member States (and Norway) into Northern, Central and Southern zones. 113 The aim is to improve efficiency, 114 avoid duplication of work, reduce administrative burdens on industry and Member States, increase harmonisation and facilitate mutual recognition of authorisations. 115 The authorisation procedure and communication and coordination between Member States are facilitated by three 'zonal steering committees', one for each zone, and an 'inter-zonal steering committee'. Neither zonal steering committees nor the interzonal steering committee is provided for in the Regulation. The zonal steering committees are chaired by participating Member States and meet every two months 'to discuss specific applications and issues arising which should be fed into' the inter-zonal steering committee. 116 An applicant seeking authorisation must submit a 'draft Registration Report', which contains information and data on the risk assessment and risk management of the pesticide, 117 to each Member State in which it intends to place the pesticide on the market. 118 Evaluation of the application is conducted at 'zonal' level by the 'zonal rapporteur Member State' whose conclusions provide the basis for final, national authorisation decisions. To avoid duplication of work, other Member States in the same zone may not proceed with the file pending zonal rapporteur Member State evaluation. 119 To facilitate efficient and swift operation of the zonal procedure, applicants 108 should request pre-submission meetings with their proposed zonal rapporteur Member State to enable discussion of the application, its potential problems, quality and strategy. 120 The zonal rapporteur Member State must make an independent, objective and transparent assessment of the application 'in the light of current scientific and technical knowledge' using available guidance documents and allowing other Member States in the same zone to submit comments for consideration in the assessment. 121 In order to determine whether the pesticide meets the requirements established in Article 29 of the Regulation, 122 it must apply the Uniform Principles. 123 The zonal rapporteur Member State must make its assessment available to the other Member States in the same zone (the 'concerned Member States') and allow an opportunity for comments. 124 The zonal rapporteur Member State may communicate with an applicant, for example to request additional information, 125 and should seek its comments on the zonal draft Registration Report. 126 The zonal rapporteur Member State produces a final assessment, in the form of a Registration Report, and decides whether to grant or refuse authorisation. 127 The concerned Member States must grant or refuse authorisations on the basis of the conclusions of the zonal rapporteur Member State. 128 Concerned Member States may still assess their own national requirements and impose appropriate conditions and 'other risk mitigation measures' in their own national authorisations. 129 In limited cases, a concerned Member State may refuse authorisation. 130
The rules of the game
The zonal evaluation and authorisation procedure operates differently in different Member States and zones, within the above framework. There are many examples but two suffice to illustrate here. Firstly, different Member States treat incomplete applications differently, with some rejecting such applications outright and requiring resubmission and others accepting submission of missing data. Secondly, some Member States treat the expert advice supplied to decision-makers on the risk assessments in applications as binding while others treat it as purely consultative. 131 As discussed in Part II, transparency in the context of this regime requires clarity with respect to the rules governing the pesticide authorisation procedure in each Member State. Such clarity meets both the practical needs of applicants and the desires of any interested parties to understand the authorisation procedure, actors involved and how information in the application is used and assessed. In terms of the law, the Regulation imposes no obligation on Member States to publish information about their national authorisation procedures and requirements. In terms of national implementation, the level of information available in different Member States is highly variable. For example, the websites of some Member State CAs (such as the UK, the Netherlands, Germany and Belgium) contain comprehensive information on application and data requirements while at least one Member State CA website publishes no information. 132 Given the procedural differences between Member States, the rules by which their procedures operate cannot be assumed or guessed. The lack, or uneven availability, of information about the rules of the game impedes understanding of evaluation and authorisation procedures amongst interested parties, undermining transparency per se and perhaps too fulfilment of the requirements for transparency discussed in Parts IV A 2 and 3 below.
Access to information
Despite its potential drawbacks, as discussed in Part II, transparency requires access to information.
Measures providing for access to information, for example, publishing decisions, the reasons for those decisions and their informational basis, and providing opportunities for interested parties to evaluate the knowledge used to justify those decisions may enhance accountability, increase trust in regulators and facilitate democratic control of discretionary decision-making.
The Regulation imposes no requirement on Member States to give reasons for their authorisation decisions, demonstrating a lack of ambition in the legislation in terms of ensuring transparency through access to information. Uniform Principle A.5 second paragraph requires Member States to 'come to a reasoned decision within 12 months of receiving a technically complete dossier' but omits a requirement for its publication. 133 The Regulation's requirements on access to information provide some measure of transparency with respect to individual pesticides and the knowledge base for decisions. Article 57 obliges Member States to keep certain information electronically available to the public on pesticides authorised or withdrawn under the Regulation. Article 60(2) requires Member States to compile and make available on request, lists of test and study reports concerning individual pesticides and the substances they contain, including those for which the applicant claimed data protection under Article 59. The lists include information on whether the reports were 'certified as compliant with the principles of good laboratory practice or of good experimental practice', 134 enabling some scrutiny of the quality of the information used in decision-making.
Beyond the legal requirements in the Regulation, Commission guidance recommends publication of the final Registration Report 'if legal provisions in the individual MS allow', minus confidential information. 135 Registration Reports contain reasons for decisions and a Reporting Table recording unresolved differences of opinion on technical issues between the zonal rapporteur Member State and concerned Member State 'for transparency reasons'. 136 Levels of publication of decisions among Member States vary. Some CAs publish all authorisation decisions while some publish most or only some. The French CA, for example, publishes the conclusions of its evaluation and part of the Registration Report for the purposes of transparency. 137 Some do not publish decisions to reject applications, perhaps due to classifying this information as commercially confidential. Very few Member States publish the information on which decisions are based or the Registration Reports, though they may be accessible through national legislation on access to information. 138 While mere guidance is unable to compel disclosure, Member States are discussing 132 Ibid, pp 90-91. 133 Uniform Principles, note 123 above. 134 PPPR, Art 60(3). 135 Commission, note 116 above, p 14. 136 Ibid, p 13. 137 ANSES, Press Kit: New missions for ANSES in the area of plant protection products, fertilisers and growing media (2015), p 7. 138 Hamlyn, note 4 above, pp 91-93. publication of Registration Reports, indicating an appetite to enhance transparency through national implementation of norms found in guidance, despite the lack of legal requirements. 139 Furthermore, the content of Registration Reports suggests that at least some parts would be disclosable under Article 4(2) Directive (EC) 2003/4, 140 which provides that CAs may not refuse disclosure of 'information on emissions into the environment', unless one of the limited exceptions in paragraphs (b), (c) or (e) applies. 141 The CJEU, in Bayer, 142 endorsed a broad interpretation of 'emissions … into the environment, affecting or likely to affect' the environment, 143 finding that it covered emissions of pesticides and the substances contained in them. 144 Although the CJEU limits information disclosable to that relating to actual or foreseeable emissions under 'normal and realistic conditions of use', 145 and despite remaining ambiguity, 146 this interpretation may mean large amounts of data and studies are disclosable, under the guidelines laid down by the CJEU for CAs, including importantly, information on the medium-to long-term consequences of emissions on the environment. 147 More recently, the CJEU extended this interpretation to similar provisions requiring EU institutions to disclose information which 'relates to emissions into the environment'. 148 In these judgments, the CJEU explicitly recognises that the public require access to information relating to emissions into the environment to check whether the assessments on which CAs base their authorisation decisions are correct and to understand the effects of emissions on the environment, in order thereby, to review the justifications for those decisions. 149 Finally, these cases suggest the incremental spread of transparency illuminating the pesticides regulatory landscape; something which may continue in the future.
The increased availability of such information certainly has the potential to enhance transparency. However, simply disclosing information is often insufficient; the information itself must be 'intelligible, clear and ultimately accountable'. 150 If Registration Reports are of poor quality or available solely in the national language, publication may provide only limited improvements in transparency. 151 Furthermore, the communication of information must be audience-sensitive to be effective. 152 Even this is not straightforward; public communication activities that purport to disseminate factual information in the interests of transparency may instead seek to effect social control through manipulating public opinion and influencing behaviour. 153 Finally, the capacity of the recipient of the information to appraise and use that information matters. Transparency differs little from concealment in a society lacking 'an active interpretive culture willing to criticise and able to make sense' of the disclosed information. 154 In the highly specialised world of pesticides, review by any scientific expert may not be enough; the right expert is required, and even they must be sufficiently detached from the subject matter to ensure unbiased review. 155 Overall, the Regulation imposes no requirement on Member States to publish their assessments, decisions on authorisation and the reasons and information behind decisions. As Bayer and experience of EU level litigation over access to documents suggest, 156 even with rights established in legislation, access in practice may remain challenging. Finally, publishing decisions is a relatively unambitious form of accountability, 157 suggesting the importance of the openness of the entire decision-making process. 158
Public participation
Part II highlighted the link between wider participation in decision-making and enhanced transparency, and a consequential increase in accountability, trust in regulators and public support for decisions. Furthermore, in circumstances characterised by high levels of complexity and social and ecological uncertainty, engaging with a broad range of participants contributing different knowledge and values, may generate better decisions, aid identification of errors and help solve problems.
In terms of legal requirements, the Regulation contains no provision for public or stakeholder engagement during either the zonal evaluation or national authorisation procedures. With respect to the operation of national procedures, again, Member State practice varies, with some CAs consulting, for example, farmers and other pesticide users or other actors involved in plant protection. 159 Evidence suggests that few, if any, CAs consult wider industry, civil society organisations (CSOs) or publics. Indeed, Member States would not welcome wider participation due to, amongst other things, fear of NGO pressure and the influence of non-scientific opinions or public opinion in the decision-making process. Furthermore, despite provision, in the Regulation and guidance, of opportunities for contact between zonal rapporteur Member States and applicants during evaluation (discussed above), few zonal rapporteur Member States appear to maintain good channels of communication with applicants in practice. 160 That said, evidence also suggests that industry may have regular contact with CAs at national and zonal levels on matters other than specific applications, including procedural and scientific issues, for example interpretation and implementation of the Regulation and interpretation of application and dossier requirements, and participation in annual open zonal steering committee meetings in the Central and Southern zones in which similar matters are discussed. 161
B. Why improve transparency at pesticide authorisation?
Criteria for approving active substances and authorising pesticides are complex so some detail is necessarily excluded. Article 4(1) provides that an active substance 'shall be approved … if it may be expected that [pesticides] containing that active substance meet the requirements provided for in paragraphs 2 and 3' of Article 4. Article 4(2) requires that the residues of the pesticide in question do not have 'any harmful effects on human health' or 'any unacceptable effect on the environment'. Article 4(3) requires, inter alia, that the pesticide be 'sufficiently effective' and that it has 'no immediate or delayed harmful effect on human health' and no unacceptable effects on plants, plant products or the environment. Article 4(5) provides that compliance with these requirements may be demonstrated by 'one or more representative uses of at least one' pesticide containing the relevant active substance. Active substances are assessed 'as if' they are in pesticides and 'having regard to realistic conditions of use'. 162 However, the minimum requirement for one representative use of one pesticide confines assessment, perhaps necessarily, to a certain level of generality despite the likely diverse conditions of eventual use. By contrast, the requirements for authorisation of pesticides envisage an extended range of considerations, including exposure risks posed by its technical formulation, that the nature and quality of its ingredients (active substances, safeners, synergists and co-formulants), relevant impurities and residues can be determined and that its physical and chemical properties are acceptable for appropriate use and storage. 163 Context of use shines more strongly through these requirements. For example, under Article 29(3), compliance with many requirements must be assessed 'under agricultural, plant health and environmental conditions' relevant to the use of the pesticide in question and 'representative of the conditions prevailing in the [relevant] zone'. Finally, the interaction between the ingredients in the pesticide must be considered. 164 The considerations relevant to active substance approval and pesticide authorisation differ in nature, number and context-specificity and many emerge only at the authorisation stage. That active substance evaluation does not, and probably cannot (without lengthy delays), take into account use-, context-and final product-specific criteria militates towards increasing the transparency of the stage of decision-making at which they are considered; authorisation. EFSA has conceded that the distinction between active substances and pesticides may explain the difference between its conclusions on the carcinogenic potential of glyphosate, having assessed glyphosate alone, and those of the International Agency for Research on Cancer which also assessed glyphosatebased formulations. 165 Assessment against the conditions prevailing in the relevant zone, in particular, presents a reason for wider local/national engagement in decision-making through access to relevant information and participation. Such questions may become more pertinent when closer to the publics most likely to be affected by the decision and zonal evaluation and national authorisation represent the last opportunity for those publics and stakeholders to contribute national and culture-specific concerns, values and knowledge to decision-making. There is, 161 Ibid, p 94. 162 PPPR, Arts 4(2) and (3). 163 furthermore, recognition in high-level EU policy circles, and elsewhere, that the transparency of pesticide authorisation requires improvement. 166
V. SHADES OF TRANSPARENCY AND CHIAROSCURO REGULATION
The above discussion suggests that the Regulation, overall, does not operate transparently. However, to enlighten our understanding of transparency in complex risk regulation regimes, this claim may be further nuanced. The meaning, benefits and limitations of transparency, and its implications, vary depending on context. 167 There are, furthermore, different degrees of transparency which influence its capacity to facilitate knowledge, 168 for example, the amount revealed, and the size and identity of the permitted audience. Transparency may move in different directions, illuminate either events or processes and occur in retrospect or real-time. 169 It may also manifest different forms at different times, levels of governance and depending on the purpose it serves. 170 The following discussion reinforces this understanding of transparency and elucidates additional areas of variation. Firstly, comparison between active substance approval and pesticide authorisation reveals that, even within a single regulatory regime or piece of legislation, levels of transparency can vary significantly depending on procedure and regulatory object (here, active substance or pesticide), notwithstanding the interdependence of both procedures and regulatory objects. Secondly, I highlight the almost infinitely variable levels of transparency accorded to different interested parties during pesticide authorisation.
I use the concept of 'chiaroscuro regulation' here to capture and describe certain characteristics of the regime and the nature of these variations in transparency. As discussed in Parts III B and IV A, these variations and characteristics stem from the legal requirements governing active substance approval and pesticide authorisation, their implementation -particularly national implementation of the pesticide authorisation procedure -and policy developments. 171 Firstly, the concept seeks to highlight the dramatic contrasts in levels of transparency between different procedures, levels of governance, regulatory objects and, within pesticide authorisation, different CAs. Secondly, it illustrates the idea, with respect to audience, that the same regulatory object, procedure or CA may appear visible or illuminated from some angles or perspectives but invisible or obfuscated from other angles. Finally, it acknowledges the incremental and particular nature of developments in transparency. The Commission's proposal to improve the transparency of risk assessment in the food chain (see Part III B) and CJEU case law on transparency in pesticides regulation (see Part IV A 3), while marking positive steps, will not flood the entire regime with light. Though they may shift or recede, shadows remain where improvements in transparency focus only on specific areas or are approached from specific directions. These characteristics are elaborated further below. The analysis closes with a brief discussion of some of the potential consequences of chiaroscuro regulation.
A. Active substance approval vs pesticide authorisation
The Commission acknowledges that currently transparency and confidentiality rules vary depending on the sub-area of food law. 172 However, the variations extend beyond the sub-areas into different 166 SAM, note 123 above; Storck, Karpouzas and Martin-Laurent, note 99 above. 167 Fisher, note 17 above, pp 277, 283. 168 Schauer, note 67 above, p 1345. 169 D Heald, 'Varieties of Transparency' in Hood and Heald, note 11 above. 170 C Hood, 'Transparency in Historical Perspective' in Hood and Heald, note 11 above. 171 I am grateful to the editors/anonymous peer reviewer, for clarifying this point. 172 Commission, note 108 above, p 3. procedures within the Regulation. As discussed in Part III B, though not ambitious, active substance approval enjoys some degree of transparency and garners the vast majority of current proposed transparency-related improvements. The determinants of issue salience are complex. However, the glyphosate and neonicotinoid (all active substances) controversies may constitute 'focusing events' which, combined with media attention, increase visibility and channel items onto the political agenda. 173 Occurrence at EU level and the high profile of EFSA and the Commission make active substance approval visible and perhaps therefore an obvious target for attention, despite its distance from EU citizens.
By contrast, pesticide authorisation offers little transparency although, as discussed in Part IV A, there is some variation between Member States. Potential reasons may include the lower profile of pesticides and lower visibility of national decision-making partly stemming from the absence of detail on the operation and institutions of the zonal system on the face of the legislation. 174 For example, the Regulation does not mention zonal steering committees. They are mentioned only in guidance, 175 which establishes a very loose framework for their operation and omits detailed norms pertaining to transparency, although part of their remit is to ensure transparency. 176 Regulatory regimes are not delimited by legal instruments but rather extend to 'the norms, the mechanisms of decision making, and the network of actors … involved in regulation'. 177 Risk regulation regimes, such as that examined here, consist in 'the complex of institutional geography, rules, practice, and animating ideas that are associated with the regulation of a particular risk or hazard', extending to 'highly fragmented administration and complex overlapping systems controlling related aspects of a risk'. 178 Thus, in a decentred regime, the role of state law may diminish, ceding space to other forms and sources of norm-generation, for example guidance. 179 Vaughan has argued that a function of post-legislative guidance, such as that mentioning zonal steering committees, is to 'extrapolate' from the legal text where that text is silent. The aim is to fill a gap left by that silence where necessary to ensure operation of the legislation in question, 180 ie, the Regulation. Here, zonal steering committees themselves and the rules on their functioning are necessary for the zonal system to work.
Procedures for adopting soft post-legislative acts (such as guidance) may themselves lack transparency due to, inter alia, the absence of information about participating stakeholders, wider consultations and oversight by the Council, Parliament or comitology. 181 Indeed, the Commission's guidance document on zonal evaluation, which mentions zonal steering committees, 182 discloses scant information as to its genesis. On the other hand, this is arguably a small price to pay if the guidance or rules enhance legal certainty or the effective operation of the regime. 183 However, there is evidence of industry influence, at a zonal level, on the development of zonal practice, 184 which may pose problems, as discussed further in Part V C. Furthermore, in addition to the manner of adoption, the arrangements instituted by guidance, once established, may remain adumbrated. Discovering the existence of, and information about, zonal steering committees requires effort and some initial knowledge of what one is searching for, itself hard to obtain. Once discovered, zonal steering committees are inaccessible. For example, the Central zonal steering committee publishes some information on matters such as meetings or evaluation procedures on CIRCABC -an EU online communication and information resource centre with some publicly available pages. However, users require a (free) account and locating relevant documents is not straightforward. Overall, pesticide authorisation remains in the shadows.
It is noticeable that active substance approval, which, compared to pesticide authorisation, is the more transparent procedure under the Regulation, attracts proposals for transparencyenhancing reforms. Risk regulation regimes have faced increasing, though not universal, pressures for more openness. Such pressures do not necessarily coincide with low initial levels of openness and vary in terms of responses to pressures and elements of the regime targeted for increased openness. 185 Here, it may be that the limited transparency of active substance approval acts as a baseline from which to demand more, whereas the obscurity of pesticide authorisation, particularly the zonal system, raises the question whether there is enough knowledge of it in the first place to provoke agitation for more.
B. Differential transparency in pesticide authorisation
Despite an overall lack of transparency in the pesticide authorisation procedure, there are occasional flashes of transparency from some CAs, benefiting certain audiences. Regarding applicants, the availability of pre-submission meetings and the communication between CAs and applicants, for example during evaluation, help clarify the rules of the game and enable greater access to the regulator's decision-making process. This suggests increased transparency, although the prevalence of these practices varies according to CA, as discussed in Part IV A 3. 186 Greater transparency to wider industry may also be indicated by the 'regular contact' with CAs at national and zonal level outside specific applications. 187 This suggests potential for some involvement by industry in the operation of the regime generally, including input into shaping its implementation and questions of interpretation. However, industry is not monolithic and these limited instances of transparency do not extend to every industry actor. The inaccessibility of original Registration Reports, for example, disadvantages the generic pesticide industry for whom they represent valuable guidance for putting together applications. 188 Citizens and CSOs, by contrast, tend to experience much lower levels of transparency. Given the lack (with a few exceptions) of clear information from CAs about national authorisation procedures, the challenges of accessing information and an absence of opportunities for wider public participation in decision-making, as discussed in Part IV A, the pesticide authorisation procedure is not transparent with respect to publics and wider civil society. PAN-Europe notes that a drawback of zonal authorisation is the variable practices of stakeholder representation and transparency amongst Member States, as opposed to the Commission's flawed, but 'fair' policy of stakeholder representation and transparency. It also expresses concern regarding close relationships between Member States and industry while other stakeholders are kept at a distance. 189 CSOs have expressed a similar sentiment with respect to active substance approval where they believe industrial interests are favoured over the public interest. 190 As discussed above, a feature of the zonal system is its obscurity and distance from citizens/CSOs, of whom few may be aware of its existence or procedures and of whom many may not have the resources to discover more, let alone participate.
In sum, in the context of a highly complex, polycentric and decentred multi-actor regulatory regime, it is impossible to draw final conclusions identifying a single level of transparency which holds true for the entire regime, including its implementation by Member States, both now and in the future. There are contrasts in transparency, depending on the relevant procedure, and the shades of transparency, even within one procedure, are almost innumerable. Overall, transparency varies according to individual regulator practice, actor or audience, level of governance, regulatory procedure and regulatory object. Its evolution, furthermore, appears influenced by existing levels of transparency and the high profile (or otherwise) of the regulatory object, reflecting further the incremental, particular and contingent nature of developments in transparency. Even if, therefore, a decision is made at EU level which, as a supranational decision-making procedure, may arguably seem further removed from citizens than zonal or national levels, if it is controversial or already visible, drives to improve transparency may be stronger.
C. Consequences of chiaroscuro regulation
Transparency is not necessarily an unalloyed good. It may have unintended consequences and requires more than simply 'turning on the light'. 191 Increasing transparency may jeopardise other important goals or values. 192 There are, for example, arguments for secrecy or concealment and transparency may have to compete with other important social values which differ, depending on context. 193 Commercial confidentiality, 194 national security and the protection of personal data are all in tension with transparency. 195 So too, are other valued objects such as effectiveness, fairness and legitimacy as well as trust and accountability themselves. 196 Furthermore, non-disclosure may be valuable for promoting honesty and frankness. 197 However, despite its complexity, transparency, alongside 'openness', is now widely accepted as a principle of good governance. Some argue it is a general administrative law principle. 198 Others contend it is a general principle of EU law. 199 Similarly, 'openness', interpreted as communication about EU activity and decisions in 'accessible and understandable' language, is recognised by the 189 Commission as a principle of good governance. 200 Although 'there is no necessary or automatic link between transparency and other values', 201 it has the potential to offer multiple benefits. As discussed above, it is regarded as key to ensuring greater public accountability. Furthermore, though arguable, it may increase public trust or confidence in a regulator and decision-making process. It is linked, in the eyes of many, including the EU, to trust and legitimacy. 202 For example, as a principle which facilitates citizen participation in decision-making, transparency is intended to 'guarantee that the administration enjoys greater legitimacy and is more effective and more accountable to the citizen'. 203 More specifically, there are good reasons for enhancing the transparency of pesticide evaluation and authorisation separate to the measures taken with respect to active substance approval. 204 In its current form, the Regulation, particularly pesticide authorisation, is unable to reap such benefits. Furthermore, the potential for context-specific knowledge to enhance the quality of national decisions is lost in the absence of participatory opportunities. Transparency, per se, does not guarantee the quality of decisions. However, its absence deprives interested parties of the ability to judge.
More specifically, the uneven levels of transparency between the procedures for active substance approval and pesticide authorisation raises concerns. The Commission's response to the ECI, while arguing that it had no basis for banning glyphosate, notes that Member States must still evaluate all authorisations for pesticides containing glyphosate and may themselves impose a ban or restrictions where warranted on evidence related to the particular circumstances in their territories. 205 While technically true, this overlooks the real danger that post-active substance approval, subsequent pesticide evaluation and authorisation will disappear into the shadowy zonal system, unilluminated by any formal transparency mechanisms to support public scrutiny, contributions to or influence of decision-making. Citizens are entitled to know which pesticides are authorised in their territory and the reasons and data behind the specific, national decision. The European Parliament has described the existing system of access to information as 'totally obstructive', 206 arguing that 'the public should be entitled to access the information on the chemicals they are exposed to'. 207 The EU's Scientific Advice Mechanism (SAM) notes that there is 'no complete single overview of which pesticides are authorised, including where they are authorised in the EU and for which uses, as well as their market penetration and actual use'. 208 Ultimately, it is no less important, given the requirements for pesticide authorisation discussed in Part IV B, that national citizens are able to hold national regulators to account via transparency mechanisms and contribute to decision-making, than EU citizens are with respect to EU-level actors regulators and procedures.
Differential transparency between industry generally and civil society may also have consequences. Private, economic actors (applicants) provide the majority of the information on which authorisation decisions are based. 209 Given the resources available to applicants and regulators respectively, 210 this is reasonable and may increase the cost effectiveness and efficiency of regulation. 211 It is also arguably inappropriate to use public funds to facilitate pesticide commercialisation and thereby gains which ultimately accrue to private industry. 212 Reliance on such sources does, however, raise concerns regarding information asymmetry and the potential for industry to frame or manipulate regulator perceptions through the supply of selective or biased information. 213 Likewise, contact between industry and CAs arguably improves the efficient operation of the zonal system, for example through early resolution of problems with applications (as policy intended -see Part IV A). However, industry itself is largely free from public oversight and norms militating towards openness or acting in the public interest, raising concerns regarding accountability (although alternative accountability mechanisms may operate). 214 Such collaboration may decrease the relational distance between regulator and industry, potentially increasing the risk of capture.
Transparency may respond to involvement by private, particularly economic, actors in regulation. 215 It can, for example, ensure the public knows who is involved in, and what they are contributing to, the regulatory process, granting opportunities for scrutiny and reducing information asymmetries, 216 again supporting accountability. Access to information, for example the content of pre-submission meetings, 217 may reduce the risk of capture and industry influence may decrease with increased participation by other interests. 218 Thus, transparency may facilitate democracy, enabling public control to counter corruption or regulatory capture. 219 The absence of such transparency mechanisms, and contingent accountability gains, compromises the ability of publics to counteract industry influence.
VI. CONCLUSION
The Regulation generally, and its provisions governing the authorisation of pesticides in the EU specifically, offer rich insights into transparency in the context of a highly complex, polycentric and decentred, multi-actor, transnational risk regulation regime. These insights are encapsulated in the notion of 'chiaroscuro regulation,' which describes the myriad, and sharply contrasting, variations in transparency, shaded according to actor or audience, level of governance, regulatory object, Member State practice, regulatory procedure and perhaps still other factors yet to be demystified. There is no drawing of universal conclusions about levels of transparency, even within a single regime or piece of legislation. Furthermore, drives to enhance transparency, for example Commission policy on food safety regulation including active substance approval, evidence from the recent REFIT evaluation of the Regulation, the CJEU's decision in Bayer and other recent case law, 220 and Member States' own discussions on access to information, reveal the potential for future change. 221 As such, conclusions drawn now about levels of transparency in the Regulation are not fixed, indicating the diversity of drivers of transparency and the evolution of transparency through time. Recent developments also suggest that change is contingent, as well as gradual and partial, leaving elements of the Regulation in the dark. Given the drawbacks of transparency, discussed above, some remaining darkness may arguably be desirable. However, the inumbration of certain elements of the regime, characteristic of chiaroscuro regulation, undermines enjoyment of the potential benefits of transparency. Uneven or diminished clarity regarding procedural rules and access to information at different levels of governance or with respect to different procedures or regulators reduces opportunities for public involvement and scrutiny. Differential transparency, depending on actor (put crudely, industry or civil society), weakens opportunities to counter-balance influence from a particular quarter, in this case, industry. These combine to reduce the potential for democratic accountability, better decisions or for a polity to make that judgment.
